In the context of bladder cancers the hypermethylation of Wnt antagonist genes such as Wnt inhibitory factor 1 (WIF1), mutations in adenomatous polyposis coli (APC) and aberrant expression of β-catenin have been reported to be associated with increased aggressiveness and poor prognosis[11-15]. This evidence concerns the gene APC and urinary bladder carcinoma.